ISO lists ISO/FDIS 9001 as under development. It is Edition 6 for 2026. The draft is now in the approval phase. It is expected to replace ISO 9001:2015 in September 2026. Certified organizations will need time to transition.
Why Is ISO 9001 Entering a 2026 Approval Phase?
ISO/FDIS 9001 is under development as Edition 6 and has entered the 2026 approval phase. It is expected to replace ISO 9001:2015 in September 2026. This matters because QMS teams need time to review documented information, process controls, internal audit plans, supplier quality links, management review inputs, and certification readiness before transition pressure increases.
How Could ISO 9001:2026 Impact QMS Teams?
ISO 9001:2026 could help organizations refresh their quality management system and improve process alignment. Early preparation can strengthen supplier quality, internal audit readiness, documented information, management review, and continual improvement. However, late preparation can create audit pressure, unclear process ownership, documentation gaps, supplier misalignment, and certification delays. QA, compliance, and operations teams should treat the revision as a structured transition project.
Why Does This News Matter for Pharma Professionals?
This news matters because ISO 9001 supports quality management systems across pharma suppliers, laboratories, service providers, manufacturing partners, and regulated operations. Pharma professionals should monitor the revision because supplier readiness and QMS alignment can affect compliance confidence.
QA and QMS Teams
QA and QMS teams should review documented information, process approach, quality objectives, management review, corrective action, continual improvement, and overall quality management system transition readiness.
- Map current QMS clauses early.
- Update documented information systematically.
Supplier Quality and Compliance Teams
Supplier Quality and Compliance teams should monitor supplier certification status, accredited certification, supplier qualification, QMS alignment, audit planning, and regulated partner readiness before ISO 9001:2026 transition.
- Review supplier certification timelines.
- Align supplier audits with transition needs.
Operations and Internal Audit Teams
Operations and Internal Audit teams should connect process mapping, operational ownership, risk-based thinking, audit evidence, gap assessment, internal audits, and transition planning across daily business processes.
- Run early gap assessments.
- Prepare audit evidence by process.
What Could ISO 9001:2026 Change Next?
ISO 9001:2026 may reshape QMS planning for certified organizations after September 2026. The next outcome depends on final ISO publication, certification body guidance, transition timelines, and organizational readiness. For pharma-related teams, the message is clear: QMS transition is strategic quality work, not a last-minute documentation update.
Build stronger QMS and quality readiness with Pharmuni. Explore Pharmuni courses on GMP, quality assurance, supplier management, and process improvement to understand how strong quality systems support compliance and operational excellence.
Prepare for ISO 9001:2026 before audit pressure starts. Build QMS skills with Pharmuni: read GMP vs ISO Compliance Guide for Pharma in 2026.